Arthritis Medications for Senior Pets: 2025 Pain Relief Guide

I’ll never forget the morning Mrs. Patterson carried her 11-year-old Golden Retriever into our clinic. His name was Duke. She didn’t walk him in—she carried him. This 80-pound dog once loved chasing tennis balls. Now he whimpered when she tried to help him stand.

“He just stopped being Duke,” she said with tears streaming. “I thought he was just getting old.”

Duke wasn’t just getting old. He was in pain. We started the right Arthritis Medications for Senior Pets: Pain Relief & Mobility Treatment Guide 2025 protocol. Within three weeks, he was walking again.

He wasn’t running marathons. But he was greeting her at the door. He was navigating stairs. He was living instead of just existing.

Arthritis in senior pets sneaks up gradually. We convince ourselves it’s “normal aging.” But here’s what I’ve learned in two decades as a vet: pain is never normal. And we now have more tools than ever to fight it.

Understanding What We’re Really Treating

Osteoarthritis isn’t just “stiff joints.” It’s chronic inflammation. It’s cartilage breakdown. It’s nerve problems that create a cycle of pain.

The numbers are sobering. About 80% of dogs over 8 years old have it. Studies show 90% of cats over 12 have arthritic changes. Yet cats hide it so well that we miss it often.

Your Lab who’s slowing down on walks? Your cat who stopped jumping to her favorite windowsill? They’re probably hurting.

Untreated arthritis doesn’t just make them uncomfortable. Studies show it reduces pet lifespan by an average of two years. It also significantly lowers quality of life.

Here’s the good news: we’re in a golden age of arthritis management.

The First-Line Defense: NSAIDs That Actually Work

Non-steroidal anti-inflammatory drugs remain our first choice for most senior pets. Modern veterinary NSAIDs are much better now. These include carprofen, meloxicam (Metacam), and galliprant (Galliprant).

They’re specifically made for animal metabolism. This is why you should never give your pet human ibuprofen or Tylenol.

Let me be crystal clear: human arthritis medications are toxic to dogs and cats. Ibuprofen causes severe stomach ulcers and kidney failure in dogs. Acetaminophen (Tylenol) destroys cats’ red blood cells.

I’ve seen both scenarios end tragically. It happens more often than you’d think.

The newer COX-2 selective NSAIDs like galliprant have fewer side effects. They show 30-40% fewer stomach problems than older medications. They provide the same pain relief.

For most dogs, generics cost $20-60 monthly. This makes them affordable for long-term use.

Cats are trickier. Meloxicam is the only FDA-approved NSAID for long-term cat use in the US. We use it cautiously with regular monitoring.

New extended-release forms were approved in Europe in 2024. They allow every-other-day dosing. We’re waiting on US approval. It’s a game-changer for cat owners who struggle with daily pilling.

Before We Start: The Pre-Medication Workup

Here’s where pet owners sometimes balk. But I’m firm on this: before starting any NSAID, your pet needs bloodwork.

We’re checking liver and kidney function. NSAIDs are processed through these organs. Senior pets often have compromised organ function.

Catching it early means we can either adjust dosing or choose different medications.

This isn’t veterinary upselling. It’s safety protocol. I’ve caught early kidney disease in countless “healthy” senior dogs during pre-NSAID screening. That information completely changes our treatment approach.

The New Kids on the Block: Monoclonal Antibody Therapies

Now we get to the really exciting stuff. Librela for dogs and Solensia for cats are new therapies. They’re monoclonal antibodies that target nerve growth factor (NGF).

They received FDA approval expansion in 2023-2024. They’re now widely available across the US.

Think of them as biological “smart missiles.” They specifically block pain signals. They don’t affect the liver, kidneys, or stomach.

For pets who can’t tolerate NSAIDs, they’re revolutionary. For pets who need extra pain control, they’re revolutionary.

Studies show pain relief in 70-75% of cases. Here’s the best part: no routine bloodwork monitoring required.

The catch? Cost. We’re talking $60-120 monthly depending on your pet’s size. Compare that to $20-60 for NSAIDs.

But for Mrs. Chen’s 14-year-old cat with early kidney disease, Solensia was perfect. It meant we could manage arthritis pain without worsening her kidney function. Sometimes you can’t put a price on that.

These are monthly injections given at the clinic. It takes about 30 seconds. Most pets don’t even flinch.

Bedinvetmab (Librela) now has two-year safety data published in 2024. It shows excellent long-term tolerance.

Beyond the Basics: Adjunct Medications for Tough Cases

When NSAIDs or biologics alone aren’t enough, we add more medications. Gabapentin and amantadine are now prescribed in 35-40% of moderate-to-severe arthritis cases.

They target the neuropathic pain component. This is the nerve sensitization that develops with chronic arthritis.

Gabapentin is particularly useful for cats. They tolerate it well. It’s also good for dogs with anxiety, since it has mild calming effects.

Amantadine works on NMDA receptors. It reduces “wind-up” pain. That’s when chronic pain makes the nervous system more sensitive over time.

I often compare it to a volume knob that’s been cranked up too high. Amantadine helps turn it back down.

Injectable and Transdermal Options

For pets who are impossible to pill (looking at you, cats), we have alternatives.

Transdermal medications are compounded into ear gels. They can be effective, though absorption varies.

Injectable medications give us options. These include the monoclonal antibodies. Sometimes we use compounded buprenorphine for severe flare-ups. This helps when oral medication becomes a fight between pet and owner.

The Multimodal Approach: Why Medication Alone Isn’t Enough

Here’s the truth: combination therapy works best. This means medication plus weight management, physical therapy, and targeted supplements.

It shows 50-60% better outcomes than medication alone. The 2024 AAHA pain management guidelines emphasize this approach for good reason.

Duke, our Golden Retriever from earlier? His protocol included galliprant, yes. But also more.

He went on a 15-pound weight loss program. Every extra pound matters. He got omega-3 fatty acid supplementation for anti-inflammatory effects. He had twice-weekly hydrotherapy sessions once he was comfortable enough to move.

Glucosamine and chondroitin supplements have mixed evidence. But many pets seem to benefit from quality joint supplements. I view them as supporting players, not stars. They’re helpful additions to a medication-based protocol.

Physical therapy isn’t just for human athletes anymore. Therapeutic laser helps. Underwater treadmills help. Targeted range-of-motion exercises help maintain muscle mass and joint mobility.

Even at-home exercises make measurable differences. Gentle leash walks work. Cavaletti pole work works.

When Things Don’t Go As Planned

What if the first medication doesn’t work? This happens. It doesn’t mean we’re out of options.

We typically follow a step-up protocol:

Start with an NSAID. If it’s not enough after 2-3 weeks at appropriate dosing, we make changes. We either switch NSAIDs or add gabapentin or amantadine. Some pets respond better to one NSAID than another.

Still not enough? Consider adding monoclonal antibodies. Or transition entirely to biologics if NSAID side effects emerge.

For severe cases, we’re seeing more general practices offer platelet-rich plasma (PRP) and stem cell therapies. These were previously only available at specialty hospitals.

These regenerative treatments became more accessible in 2024-2025. They’re expensive—$1,500-3,000 per treatment. But some pets show remarkable improvement.

Monitoring and Safety: The Non-Negotiables

If your pet’s on NSAIDs, expect recheck bloodwork every 6-12 months. We’re watching for liver enzyme elevations or kidney value changes. These signal we need to adjust course.

Watch for warning signs at home. These include vomiting, diarrhea, decreased appetite, increased thirst, or dark/tarry stools. These warrant immediate veterinary contact.

For monoclonal antibodies, monitoring is less intensive. But we still want regular check-ins to assess pain relief effectiveness.

Special Considerations: When Standard Protocols Need Tweaking

Breed matters. Large-breed dogs develop arthritis earlier and more severely. This includes Labs, German Shepherds, and Rottweilers.

Hip and elbow dysplasia set them up for early cartilage degeneration. These breeds often need intervention by age 6-7. Don’t wait until senior years.

Maine Coon cats have high arthritis rates due to hip dysplasia. Scottish Folds face joint issues from their genetic mutation.

Knowing your pet’s breed predispositions helps us screen early. We can intervene proactively.

For pets with concurrent kidney or liver disease, our medication choices narrow. This is common in seniors. This is where biologics shine. Or we use lower NSAID doses with more frequent monitoring.

Sometimes we need specialist consultation for complex cases.

The Cost Reality: Making Treatment Affordable

Let’s talk money because it matters.

Generic carprofen runs $20-30 monthly for a medium dog. Librela? $80-120 depending on size.

Add supplements and potential physical therapy. Add monitoring bloodwork. Annual costs range from $500 to $2,000+.

Cost-saving strategies exist. Use generics over brand names when equivalent. Try prescription discount programs through GoodRx or pet-specific programs. Use compounding pharmacies for certain medications.

Some veterinary practices offer wellness plans that bundle arthritis management.

But here’s my honest take after seeing thousands of cases: the cost of untreated arthritis is higher.

It comes in reduced lifespan. It comes in diminished quality of life. It comes in the heartbreak of watching your pet suffer.

These costs far exceed the cost of management. And unlike emergencies requiring immediate expensive intervention, arthritis management is plannable. It’s budgetable.

Reading Your Pet: How to Know If It’s Working

Give medications 2-3 weeks to reach full effect.

Look for subtle improvements. Increased willingness to walk. Easier time getting up from lying down. Return of playfulness or grooming behaviors in cats. Improved mood.

Keep a pain journal. Rate your pet’s mobility, activity level, and apparent comfort daily on a 1-10 scale.

Patterns emerge. These help us assess medication effectiveness objectively. We’re not just relying on memory.

If you’re not seeing improvement within 3-4 weeks, contact your vet. Don’t suffer through ineffective treatment. We have other options to try.

When Arthritis Becomes a Crisis

Sometimes arthritis pain escalates to a quality-of-life crisis.

Your pet won’t eat. They can’t stand to eliminate. They show signs of severe distress.

This warrants immediate veterinary attention. Even after hours.

We can provide injectable pain relief. We can provide short-term stronger medications. We can help you assess whether current management needs complete overhaul.

These moments are scary but addressable. You’re not overreacting by seeking urgent care.

The Emerging Frontier: What’s Coming Next

CBD products specifically formulated for veterinary use are showing promise. Preliminary studies show benefits for arthritis pain. But FDA approval is still lacking.

Until we have better data and regulation, I remain cautiously optimistic. But I can’t officially recommend them.

Nerve growth factor antibodies might have competition soon. Other biological targets are being researched. Gene therapies for cartilage regeneration are in early trials.

The field is moving fast.

Final Thoughts

Arthritis doesn’t have to be the end of your senior pet’s good years.

With the range of medications available in 2025, we can help. These include tried-and-true NSAIDs. They include innovative monoclonal antibodies. They’re supported by physical therapy and smart supplementation.

We can keep most arthritic pets comfortable and active well into their golden years.

The key is early recognition. The key is appropriate workup. The key is willingness to adjust treatment as needed.

Mrs. Patterson’s Duke lived another three comfortable years after we started treatment. He was swimming in the lake. He was snoozing in sunbeams right up until the end.

If you’ve noticed your senior pet slowing down, don’t ignore it. If they’re struggling with stairs or seeming less enthusiastic about activities they once loved, don’t write it off as “just getting old.”

Schedule a veterinary exam. Bring video of your pet at home. We often see different behavior in the clinic than you see at home. Those videos are incredibly helpful.

Together, we’ll create a pain management plan tailored to your pet’s specific needs. We’ll consider their health status and your budget.

Your senior companion has given you years of love. Let’s make sure their final years are filled with comfort, not quiet suffering.

Sources & Further Reading

• American Animal Hospital Association (AAHA) — 2024 pain management guidelines and multimodal arthritis treatment protocols
• FDA Center for Veterinary Medicine — Approved arthritis medications for pets, including Librela and Solensia safety information and monitoring guidelines
• American Veterinary Medical Association (AVMA) — Pet arthritis information, medication safety resources, and client education materials
• Cornell University College of Veterinary Medicine — Arthritis research updates and evidence-based treatment recommendations
• Veterinary Information Network (VIN) — Peer-reviewed client education on arthritis medications, side effects, and monitoring protocols

Animal Hospital Clinic